Talagrand-Reboul, E.; Westermann, B.; Raess, M.A.; Schnell, G.; Cantero, P.; Barthel, C.; Ehret-Sabatier, L.; Jaulhac, B.; Boulanger, N.
Proteomic as an Exploratory Approach to Develop Vaccines Against Tick-Borne Diseases Using Lyme Borreliosis as a Test Case. Vaccines 2020, 8, 463.
https://doi.org/10.3390/vaccines8030463
AMA Style
Talagrand-Reboul E, Westermann B, Raess MA, Schnell G, Cantero P, Barthel C, Ehret-Sabatier L, Jaulhac B, Boulanger N.
Proteomic as an Exploratory Approach to Develop Vaccines Against Tick-Borne Diseases Using Lyme Borreliosis as a Test Case. Vaccines. 2020; 8(3):463.
https://doi.org/10.3390/vaccines8030463
Chicago/Turabian Style
Talagrand-Reboul, Emilie, Benoit Westermann, Matthieu A. Raess, Gilles Schnell, Paola Cantero, Cathy Barthel, Laurence Ehret-Sabatier, Benoit Jaulhac, and Nathalie Boulanger.
2020. "Proteomic as an Exploratory Approach to Develop Vaccines Against Tick-Borne Diseases Using Lyme Borreliosis as a Test Case" Vaccines 8, no. 3: 463.
https://doi.org/10.3390/vaccines8030463
APA Style
Talagrand-Reboul, E., Westermann, B., Raess, M. A., Schnell, G., Cantero, P., Barthel, C., Ehret-Sabatier, L., Jaulhac, B., & Boulanger, N.
(2020). Proteomic as an Exploratory Approach to Develop Vaccines Against Tick-Borne Diseases Using Lyme Borreliosis as a Test Case. Vaccines, 8(3), 463.
https://doi.org/10.3390/vaccines8030463